SYNERGISTIC COMBINATION OF RDCFV2 AND RDCVF2L FOR THE TREATMENT OF TAUOPATHIES Application WO-2023280926-A1 World Intellectual Property Organisation (WIPO) 12 Jan 2023
NPTN65 IS A NEW TARGET FOR THE TREATMENT OF TAUOPATHIES Application WO-2021140215-A1 World Intellectual Property Organisation (WIPO) 15 Jul 2021
CONSTRUCTS COMPRISING NEURONAL VIABILITY FACTORS AND USES THEREOF Application WO-2019122403-A1 World Intellectual Property Organisation (WIPO) 27 Jun 2019
METHODS OF EXPRESSING A POLYNUCLEOTIDE OF INTEREST IN THE CONE PHOTORECEPTORS OF A… Application WO-2019077159-A1 World Intellectual Property Organisation (WIPO) 25 Apr 2019